News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Western Digital recommended as a buy after a Toshiba-driven selloff seen as overdone versus fundamentals.
  • WDC trades near 14.6x EPS with strong free cash flow and low leverage, supporting potential valuation upside.
  • Procore flagged as a levered long to capture upside if non‑residential construction reaccelerates.
  • Trade idea pairs a Broadcom short for visible downside with a Marvell long for underappreciated growth and margin optionality.
  • All ideas specify entries, stops and targets with multi‑month horizons for disciplined risk management.

Latest Articles

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

Assembly Biosciences reported favorable Phase 1a clinical trial results for its investigational drug ABI-6250, demonstrating safety, tolerability, and effective target engagement in healthy participants. The oral NTCP inhibitor showed dose-dependent and reversible bile acid increases without serious adverse events. These promising findings support …

Goldman Lowers Rating on Carl Zeiss Meditec, Citing Valuation-Substance Gap

Goldman Lowers Rating on Carl Zeiss Meditec, Citing Valuation-Substance Gap

Goldman Sachs has downgraded Carl Zeiss Meditec from Neutral to Sell and trimmed its price target to €23.00 from €27.00, citing a valuation that exceeds the company’s underlying fundamentals. The bank forecasts further downside as buying support fades, and it has reduced adjusted EBITDA and organic growth projections across FY26-FY28 and FY27-29 re…

Chevron Set to Retest Records as Oil Rally Reinforces Cash Flow Thesis

Chevron Set to Retest Records as Oil Rally Reinforces Cash Flow Thesis

Chevron's mix of upstream exposure, accelerating LNG capacity, and a pristine balance sheet make the company a tactical long as crude trades materially higher. Strong free cash flow, a 3.4% yield, and a manageable 0.2x debt-to-equity ratio support buybacks and dividends that can compress valuation gaps — we lay out an entry, stop and target with a …

SSR Mining: Cashed Up and Re-Primed — The Re-Rate Has Room to Run

SSR Mining: Cashed Up and Re-Primed — The Re-Rate Has Room to Run

SSR Mining (SSRM) transformed its balance sheet after selling Çöpler and now sits with roughly $1.8B in cash, zero debt and meaningful free cash flow. The market has re-rated the stock sharply, yet valuation metrics (EV/EBITDA ~5.2x, EV/Sales ~2.6x) and company-level catalysts suggest the recovery isn't fully priced in. We lay out an actionable lon…

Uniti Fiber and New Orleans Saints Announce Fiber-Backed Partnership to Support Connected Gameday and Business Operations

Uniti Fiber and New Orleans Saints Announce Fiber-Backed Partnership to Support Connected Gameday and Business Operations

Uniti Fiber has announced a strategic partnership with the New Orleans Saints to deliver scalable, high-capacity fiber connectivity supporting critical business operations and connected fan experiences at the Caesars Superdome and Saints facilities. This collaboration aims to bolster operational resilience, ensure network reliability during gameday…

AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential

AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential

AIM ImmunoTech emphasizes recent media coverage evidencing Ampligen's broad-spectrum antiviral capabilities, including its potential role in combating emerging viral threats and post-viral diseases like Long COVID. The company also underscores the expansion of its intellectual property portfolio and ongoing clinical programs focused on oncology app…

NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

NeuroOne Medical Technologies Corporation reported preliminary fiscal Q4 2026 product revenue of approximately $3.8 million, a 38.4% increase year-over-year, and full-year product revenue of about $10.5 million, hitting the top of its guided range. The company secured its largest-ever purchase order of $4.5 million in September 2026, boosting open …

Weyerhaeuser: Buy the Land, Not the Lumber Cycle - A 180-Day Value Trade

Weyerhaeuser: Buy the Land, Not the Lumber Cycle - A 180-Day Value Trade

Weyerhaeuser (WY) is pricing its timberland below what buyers have recently paid for comparable acres. The combination of a recurring dividend (yield ~4.55%), an active $1B buyback program, a $375M, 117,000-acre acquisition that boosts Southern timber cash flows, and an obvious disconnect between NAV-focused buyers and the stock market creates a de…

Maris-Tech Receives Pilot Order for Armored Vehicle Situational Awareness Application from a Leading Global Defense Industry

Maris-Tech Receives Pilot Order for Armored Vehicle Situational Awareness Application from a Leading Global Defense Industry

Maris-Tech Ltd., a leader in AI-powered edge computing for defense, has received a pilot order through a distributor for its Jupiter product line adapted for armored vehicle situational awareness from a leading global defense company. The successful pilot could lead to significant follow-on orders and expands the application potential of their tech…

iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

iRhythm Holdings, Inc. has completed its acquisition of VitalConnect, a leader in wearable biosensor technology and ambulatory cardiac monitoring. This acquisition broadens iRhythm's cardiac monitoring portfolio, adds complementary mobile cardiac telemetry and multi-vitals capabilities, and expands its addressable market across ambulatory, inpatien…

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

Capricor Therapeutics announced encouraging 24-month results from its HOPE-3 open-label extension trial of Deramiocel, a cell-based therapy for Duchenne muscular dystrophy. Patients starting Deramiocel after placebo experienced a 76% reduction in upper limb function decline compared to their prior year, reinforcing earlier 12-month findings. Both t…

JAKKS Pacific to Debut Doll Haus of Dread™ at New York Comic Con; Horror's Most Iconic Fiends Dressed to Kill

JAKKS Pacific to Debut Doll Haus of Dread™ at New York Comic Con; Horror's Most Iconic Fiends Dressed to Kill

JAKKS Pacific, a leading US toy maker, announced the launch of Doll Haus of Dread™, a new collectible fashion doll line featuring iconic horror movie characters like Ghost Face, Billy the Puppet, Jason Voorhees, and Pinhead. The dolls, priced at $39.97 each, will be available exclusively at Walmart and Walmart.com starting Fall 2026. This line mark…

LPL Financial Welcomes Praxis Financial Partners

LPL Financial Welcomes Praxis Financial Partners

LPL Financial announced the addition of Praxis Financial Partners, a wealth management firm with approximately $1.1 billion in assets under advisory, to its broker-dealer and RIA platform. The Praxis team chose LPL for its flexibility, advanced planning capabilities, and innovative technology, enabling them to maintain independence while enhancing …